<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01397487</url>
  </required_header>
  <id_info>
    <org_study_id>2009/0416</org_study_id>
    <nct_id>NCT01397487</nct_id>
  </id_info>
  <brief_title>Effects of Day 3 Blastomere Biopsy on Human Embryos</brief_title>
  <acronym>BB</acronym>
  <official_title>Effects of the Blastomere Biopsy of Day 3 Human Embryos on Blastocyst Percentage, Cell Number of Obtained Blastocyst and Implantation Rate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion Para La Investigacion Hospital La Fe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion Para La Investigacion Hospital La Fe</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study to evaluate the effect of embryo biopsy on blastocyst development and
      implantation rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preimplantation genetic diagnosis (PGD) was initially developed to prevent monogenic
      diseases. However, its use has been extended to improve pregnancy rates in assisted
      reproductive techniques (ART). These new indications has been called screening for aneuploidy
      (PGS, preimplantation genetic screening). The current indications for PGS include advanced
      maternal age, recurrent miscarriage, repeated implantation failure, severe male factor
      infertility, previous aneuploid pregnancy, poor embryo quality, chemotherapy and radiotherapy
      and elective single embryo transfer to avoid multiple pregnancies. Nevertheless, the results
      obtained in the last decade have failed to clearly demonstrate any benefit of PGS in these
      indications and there are no studies evaluating the effect that biopsy could produce on
      embryos.

      Markers of embryo quality are still very limited and are based on subjective morphological
      parameters (such as cell number, size and degree of fragmentation) or on the study of
      embryonic development by measuring the percentage of embryos reaching the blastocyst stage
      after 120 hours of in vitro culture. Counting the cell number of blastocysts involves the
      staining and subsequent nuclei counting, which is incompatible with later embryo transfer. A
      valid alternative to avoid nuclear staining would be a morphometric study using optical
      sections of different focal planes of the blastocyst and three dimensional (3D) virtual
      reconstructions.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blastocyst percentage</measure>
    <time_frame>after 120 hours of culture</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of cells of blastocyst measured by morphometric analysis</measure>
    <time_frame>after 120 hours of culture</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>after one month of embryo transfer.</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Blastomere Biopsy Safety</condition>
  <arm_group>
    <arm_group_label>one single arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients are included to complete a biopsy of half part of the embryos</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blastomere biopsy</intervention_name>
    <description>The blastomere biopsy will be done after 72 hours of embryo culture. An inverted microscope Olympus IX70 with a heated stage will be used to perform the biopsy. The micromanipulation for the blastomere extraction will be made with a micropipette MBB-FP-M-30 (Humagen).</description>
    <arm_group_label>one single arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No relevant medical history.

          -  BMI &lt; 25.

          -  Age &lt; 35 years old.

          -  Unexplained infertility, tubal or male cause of infertility.

          -  Between 6 and 8 embryos on day 3 of embryo culture.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Pellicer, MDPhD</last_name>
    <role>Study Director</role>
    <affiliation>La Fe Hospital. Dept. of Obstetrics and Gynecology.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amparo Mercader, P.h.D</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Valenciano de Infertilidad. PGD Laboratory.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Inmaculada Molina Botella, P.h.D</last_name>
    <phone>0034 961244660</phone>
    <email>mamobo1@dca.upv.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>La Fe University Hospital. Department of Obstetrics and Gynecology</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inmaculada Molina Botella, P.h.D</last_name>
      <phone>0034 619777030</phone>
      <email>mamobo1@dca.upv.es</email>
    </contact>
    <investigator>
      <last_name>Jose Pertusa, P.h.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Debón, P.h.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vicente Montañana, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Maria Rubio, P.h.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrocinio Polo, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Vicente Martinez, Biologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2011</study_first_submitted>
  <study_first_submitted_qc>July 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2011</study_first_posted>
  <last_update_submitted>July 27, 2011</last_update_submitted>
  <last_update_submitted_qc>July 27, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2011</last_update_posted>
  <responsible_party>
    <name_title>FUNDACION PARA LA INVESTIGACION HOSPITAL LA FE</name_title>
    <organization>Hospital Universitari y Politecnic La Fe</organization>
  </responsible_party>
  <keyword>morphometric parameters, embryo biopsy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

